Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Biochips and Microarrays Report 2016-2020 & 2025 - Focus on Biochips for Biomarkers, Molecular Diagnostics & Personalized & Applications of Microarrays in Drug Discovery & Development - Research and Markets | ||
By: PR Newswire Association LLC. - 23 Sep 2016 | Back to overview list |
|
DUBLIN, September 23, 2016 /PRNewswire/ -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Biochips and Microarrays - Technologies, Markets and Companies" to their offering. This report is an analysis of biochip/microarray markets based on technologies and applications. The report starts with a description of technologies as a basis for estimation of markets. Technologies include array comparative genomic hybridization (CGH), copy number variation (CNV), DNA methylation, ChIP-Chip, RNA splice variants, and microRNA. Separate chapters are devoted to protein biochips/microarrays, microfluidics and nanobiotechnology-based nano-arrays. Various applications of biochips and microarrays are described throughout the report. Areas of application such as point-of-care, genetic screening, cancer, and diagnosis of infections are included. Separate chapters are devoted to applications in drug discovery and development as well as personalized medicine The report provides current share of each segment: market size in 2015 and projected value for the years 2020 and 2025. Gene expression has the largest share and is an established market. Share of microarray technologies in other areas will grow with the maximum growth in RNA splice variants followed by epigenetics. The growth in protein microarrays is somewhat less, partly because it is more mature than the other submarkets and has already shown considerable growth in the past. Impact of next generation sequencing on segments of microarray markets is identified. Customer requirements and unmet needs are described. Markets are also analyzed according to geographical areas. Brief profiles of companies involved in biochip/microarray technologies are provided. Currently selected 92 companies are included along with listing of 120 collaborations between companies. The text is supplemented by 21 tables, 11 figures and 140 references to literature. Key Topics Covered: Executive Summary 1. Introduction 2. Biochip and Microarray Technologies 3. Microfluidics-based Biochips and Microarrays 4. Protein Biochips 5. Nanobiotechnology-based Biochips & Microarrays 6. Biochips & Microarrays for Epigenetics 7. Applications of Microarrays in Drug Discovery & Development 8. Biochips for Biomarkers, Molecular Diagnostics & Personalized 9. Markets 10. Companies 11. References For more information about this report visit http://www.researchandmarkets.com/research/zrhbvv/biochips_and Media Contact: Research and Markets Laura Wood, Senior Manager For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets |
||
|
||
Copyright 2016 PR Newswire Association LLC. | Back to overview list |